publication venue for

• ¹H-MR spectroscopy biomarkers are associated with plasma-derived biomarkers of amyloid-β and tau in the early phase of AD continuum 2026
• White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy 2025
• Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium 2024
• ¹H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults 2022
• Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia 2022
• Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies 2021
• Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease 2021
• The value of multimodal imaging with ¹²³I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia 2021
• Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study 2020
• Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity 2019
• Association of white matter microstructural integrity with cognition and dementia 2019
• Functional signature of conversion of patients with mild cognitive impairment 2019
• Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers 2019
• Translating Alzheimer's disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs 2019
• White matter in different regions evolves differently during progression to dementia 2019
• Joint associations of β-amyloidosis and cortical thickness with cognition 2018
• White-matter integrity on DTI and the pathologic staging of Alzheimer's disease 2017
• RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies 2016
• Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum 2016
• Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies 2015
• White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging 2015
• ¹⁸F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons 2014
• MULTI-TRACER IMAGING CONCEPT IN ALZHEIMER'S DISEASE 2014
• Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies 2014
• Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies 2012
• Multimodality imaging characteristics of dementia with Lewy bodies 2012
• Imaging correlates of posterior cortical atrophy 2007
• Longitudinal ¹H MRS changes in mild cognitive impairment and Alzheimer's disease 2007
• Glucose metabolic patterns in amnestic mild cognitive impairment and Alzheimer's disease; An FDG PET study 2004
• Myo-inositol/creatine ratio correlates with the neuropathological involvement in Alzheimer's disease 2004
• H-1 MRS and cognitive function in normal aging, mild cognitive impairment and Alzheimer's disease 2002
• H-1 MRS predicts development of Alzheimer's disease in patients with mild cognitive impairment and disease progression in patients with Alzheimer's disease 2002